by 
The global DNA Synthesizer Market is estimated to be valued at US$ 4.3 Bn in 2023 and is expected to exhibit a CAGR of 20% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
A DNA synthesizer is a machine that chemically synthesizes strands of DNA nucleotides, usually for research purposes. It automates the chemical synthesis of DNA and oligonucleotides. DNA synthesizers have application in areas like gene cloning, DNA sequencing, DNA barcoding, genetic disease diagnostics, DNA microarrays, and synthetic biology. The ability of DNA synthesizers to rapidly manufacture customized oligonucleotides of defined sequence paves way for advances in various medical and industrial applications areas.
Market key trends:
One of the key trends in the DNA synthesizer market is the growing demand for genetic disease diagnostics. Advanced genomics technologies have enabled identification of DNA variations associated with genetic conditions. DNA synthesizers play a vital role in manufacturing artificial DNA samples for genetic testing laboratories. More emphasis on precision medicine and early disease diagnosis is driving the requirement of custom DNA samples. Additionally, next-generation DNA sequencing for diagnosis of rare genetic disorders is augmenting the market growth. Expanding application of DNA synthesizers in research areas like gene therapy, synthetic biology and drug discovery is another major trend seen in the market. Manufacturers are launching innovative benchtop systems with increased throughput and custom DNA yields to leverage the opportunities.
Read More @ https://www.coherentmarketinsights.com/market-insight/dna-synthesizer-market-5913
Porter’s Analysis
Threat of new entrants: Low startup costs and intellectual property barriers prevent new companies from easily entering the DNA Synthesizer Market.
Bargaining power of buyers: Large biotech and pharmaceutical companies have significant bargaining power over suppliers in this specialized market.
Bargaining power of suppliers: A few major players dominate the supply of DNA synthesizers, giving them strong bargaining power over customers.
Threat of new substitutes: No viable substitutes currently exist that can replicate DNA at scale for commercial purposes.
Competitive rivalry: Major players compete on product quality, capacity, and price to gain market share in this consolidated industry.
Key Takeaways
The global DNA Synthesizer Market is expected to witness high growth, exhibiting CAGR of 20.% over the forecast period, due to increasing demand for synthesized DNA in genomic and diagnostic applications.
The North American region currently dominates the DNA Synthesizer Market, and is expected to maintain its leading position during the forecast period. This can be attributed to the large presence of key players and growing biotechnology and pharmaceutical industries in the region. However, the Asian market is expected to witness the fastest growth during the forecast period supported by growing research spending and innovations.
Key players operating in the DNA Synthesizer Market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation, GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies, DNA Script, Ribbon Biolabs GmbH, and Camena Bioscience. These players are focusing on developing new technologies to produce high-quality synthesized DNA at reduced costs.
